These emerging medications , Semaglutide , represent a groundbreaking advancement in addressing obesity and potentially associated disorders. They are classified as GLP-1 hormone agonists , indicating they to replicate the body's GLP-1 hormone , stimulating glucose production and suppressing food intake. Although Tirzepatide each one functions r… Read More